Could a 4-Hour infusion replace 20-Hour hospital stays for kids with neuroblastoma?
NCT ID NCT05421897
First seen Feb 01, 2026 · Last updated Apr 29, 2026 · Updated 6 times
Summary
This study tests whether giving the drug dinutuximab over 4 hours or less is safe and doable for children with high-risk neuroblastoma. Currently, the standard infusion takes 10-20 hours and requires a hospital stay. The goal is to see if a faster infusion can be given in an outpatient setting, reducing hospital burden and costs. The study involves 11 children aged 12 months and older with relapsed or hard-to-treat neuroblastoma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Childrens Hospital Los Angeles
Los Angeles, California, 90027, United States
Conditions
Explore the condition pages connected to this study.